Liberty One Investment Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-48,060
| Closed | -$1.01M | – | 188 |
|
|
2024
Q1 | $1.01M | Buy |
48,060
+14,218
| +42% | +$300K | 0.11% | 85 |
|
|
2023
Q4 | $607K | Sell |
33,842
-2,680
| -7% | -$48.1K | 0.08% | 106 |
|
|
2023
Q3 | $601K | Sell |
36,522
-209
| -0.6% | -$3.44K | 0.09% | 100 |
|
|
2023
Q2 | $734K | Buy |
36,731
+7,251
| +25% | +$145K | 0.1% | 102 |
|
|
2023
Q1 | $557K | Buy |
29,480
+626
| +2% | +$11.8K | 0.08% | 107 |
|
|
2022
Q4 | $654K | Sell |
28,854
-564
| -2% | -$12.8K | 0.09% | 99 |
|
|
2022
Q3 | $778K | Buy |
29,418
+1,691
| +6% | +$44.7K | 0.13% | 92 |
|
|
2022
Q2 | $1.08M | Sell |
27,727
-2,073
| -7% | -$80.5K | 0.18% | 89 |
|
|
2022
Q1 | $989K | Buy |
29,800
+277
| +0.9% | +$9.19K | 0.15% | 90 |
|
|
2021
Q4 | $965K | Buy |
29,523
+1,016
| +4% | +$33.2K | 0.15% | 102 |
|
|
2021
Q3 | $1.2M | Buy |
28,507
+780
| +3% | +$32.7K | 0.2% | 81 |
|
|
2021
Q2 | $1.08M | Buy |
27,727
+1,708
| +7% | +$66.3K | 0.18% | 89 |
|
|
2021
Q1 | $888K | Sell |
26,019
-767
| -3% | -$26.2K | 0.16% | 99 |
|
|
2020
Q4 | $1.22M | Buy |
26,786
+37
| +0.1% | +$1.68K | 0.23% | 70 |
|
|
2020
Q3 | $736K | Buy |
26,749
+7,044
| +36% | +$194K | 0.15% | 101 |
|
|
2020
Q2 | $726K | Sell |
19,705
-550
| -3% | -$20.3K | 0.16% | 80 |
|
|
2020
Q1 | $656K | Sell |
20,255
-740
| -4% | -$24K | 0.17% | 83 |
|
|
2019
Q4 | $860K | Buy |
+20,995
| New | +$860K | 0.19% | 85 |
|